LBPH实时信号 | 通过Getagraph.com最大化利润

购买 107708 min ago

@ $20.40

发出时间: 15 Feb 2024 @ 01:18

回报率: -3.33%

上一信号: Feb 14 - 04:23

上一信号: 出售

回报率: 0.94 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	179 169
平均成交量	547 767
市值	710.26M
EPS	$-0.620 ( 2024-03-14 )
下一个收益日期	( $-0.600 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.25
ATR14	$0.0350 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-08	Kaye Randall	Buy	107 560	Stock Option (Right to Buy)
2024-02-08	Kaye Randall	Buy	17 920	Common Stock
2024-02-08	Roberts Brandi	Buy	90 580	Stock Option (Right to Buy)
2024-02-08	Roberts Brandi	Buy	15 090	Common Stock
2024-02-08	Lind Kevin Robert	Buy	332 134	Stock Option (Right to Buy)

INSIDER POWER
-62.87
Last 48 transactions
Buy: 2 180 330 \| Sell: 4 964 362

音量相关性

長: -0.24 (neutral)

短: -0.16 (neutral)

Signal:(54.715) Neutral

Longboard 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Longboard 相关性 - 货币/商品

-0.58
( weak negative )

0.04
( neutral )

0.00
( neutral )

-0.17
( neutral )

0.50
( weak )

0.18
( neutral )

Longboard 财务报表

Annual	2023
营收:	$0
毛利润:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2023
营收:	$0
毛利润:	$-5 000.00 (0.00 %)
EPS:	$-2.39

FY	2022
营收:	$0
毛利润:	$-5 000.00 (0.00 %)
EPS:	$-2.51

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.648

Financial Reports:

No articles found.

Longboard

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.